Circulating tumor DNA using a plasma-only assay predicts survival in patients with oligometastatic colorectal cancer after definitive therapy
ctDNA detection after surgery/radiation in oligometastatic CRC predicts worse OS and DFS. ctDNA could help to guide the decision regarding need of adjuvant chemotherapy in this population.
Authors
- Antonio Cubillo (ORCID: https://orcid.org/0000-0001-7511-7121)
- Paloma Peinado (ORCID: https://orcid.org/0000-0001-8851-5663)
- Carmen Toledano
- Mercedes G. López (ORCID: https://orcid.org/0000-0002-0660-8119)
- Rafael Álvarez-Gallego (ORCID: https://orcid.org/0000-0002-3167-8039)
- Alicia Gonzalo
- Enrique Sanz‐García (ORCID: https://orcid.org/0000-0002-3119-3832)
- Brittany Montesino
- Yolanda Quijano (ORCID: https://orcid.org/0009-0002-6626-591X)
- O. Hernando (ORCID: https://orcid.org/0000-0002-9615-9686)
- Isabel Fabra
- Carmen Rubio (ORCID: https://orcid.org/0000-0003-1522-6152)
- César Muñoz (ORCID: https://orcid.org/0000-0002-1183-1307)
- Adrián Peláez (ORCID: https://orcid.org/0000-0003-0284-6643)
- Luka Mihic
- Emilio Vicente
- J. Domínguez Ortega (ORCID: https://orcid.org/0000-0002-8317-5230)
- Cristina Bressel
- Elena Gonzalez Lopez-Aranda
Institutions
- University of Toronto (CA)
- Instituto de Salud Carlos III (ES)
- Princess Margaret Cancer Centre (CA)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- HM Hospitales (ES)
- Camilo José Cela University (ES)
- Hospital Universitario HM Sanchinarro (ES)
- Medical Research Network (US)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.21037/jgo-24-819
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94